Mesothelin-expressing tumors
Clinical trials for Mesothelin-expressing tumors explained in plain language.
Never miss a new study
Get alerted when new Mesothelin-expressing tumors trials appear
Sign up with your email to follow new studies for Mesothelin-expressing tumors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug CT-95 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called CT-95 in people with advanced cancers that have a protein called mesothelin on their cells. The main goals are to find a safe dose and see if the drug can shrink tumors. About 70 adults with ovarian, lung, pancreatic, or other mesoth…
Matched conditions: MESOTHELIN-EXPRESSING TUMORS
Phase 1 • Sponsor: Context Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Engineered immune cells take on stomach cancer in early trial
Disease control Recruiting nowThis early-phase trial is testing a new type of immunotherapy called CAR T-cells for people with a specific kind of stomach and esophageal cancer that has spread to the lining of the abdomen. The treatment involves collecting a patient's own immune cells, modifying them in a lab …
Matched conditions: MESOTHELIN-EXPRESSING TUMORS
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC